LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and apoptosis in colorectal cancer via PPAR signaling pathway based on bioinformatics analysis
Author:
Zhang Xuexiu1, Yao Jianning1, Shi Haoling2, Gao Bing1, Zhang Lianfeng1
Affiliation:
1. Department of Gastroenterology , The First Affiliated Hospital of Zhengzhou University , No. 1 Jianshe East Road of Erqi District , Zhengzhou 450052, Henan , China 2. Department of General Surgery , The First People Hospital of Zhengzhou , Zhengzhou 450004, Henan , China
Abstract
Abstract
The present study aims to determine the potential biomarkers and uncover the regulatory mechanisms of the long-noncoding RNA (lncRNA) TINCR/miR-107/CD36 axis in colorectal cancer (CRC). Aberrantly-expressed lncRNAs and differential-expressed genes were identified by analyzing the dataset GSE40967. Gene set enrichment analysis was employed, and Cytoscape software helped in establishing the co-expression network between lncRNAs and genes. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis contributes to examining the expression levels of lncRNA TINCR, miR-107 and CD36. The dual luciferase assay was used to validate the association between miR-107 and lncRNA TINCR or CD36. The EdU incorporation assay was employed, and flow cytometry was employed to detect cell apoptosis with the tumor xenograft model being utilized. Significantly dysregulated lncRNAs and mRNAs were identified. The peroxisome proliferator-activated receptor (PPAR) signaling pathway in CRC tissues was down-regulated. The loss of TINCR expression was associated with CRC progression. The expression levels of the TINCR and CD36 were down-regulated. We identified miR-107 as an inhibitory target of TINCR and CD36. Overexpression of TINCR could inhibit cell proliferation and promote apoptosis. MiR-107 overexpression in CRC cells induced proliferation and impeded apoptosis. A regulatory function of the lncRNA TINCR/miR-107/CD36 axis in CRC was revealed. LncRNA TINCR overexpression exerted suppressive influence on CRC progression through modulating the PPAR signaling pathway via the miR-107/CD36 axis.
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference39 articles.
1. Ayremlou, N., Mozdarani, H., Mowla, S.J., and Delavari, A. (2015). Increased levels of serum and tissue miR-107 in human gastric cancer: correlation with tumor hypoxia. Cancer Biomark. 15, 851–860. 2. Benderska, N. and Schneider-Stock, R. (2014). Transcription control of DAPK. Apoptosis 19, 298–305. 3. Borland, M.G., Kehres, E.M., Lee, C., Wagner, A.L., Shannon, B.E., Albrecht, P.P., Zhu, B., Gonzalez, F.J., Peters, J.M. (2018). Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells. Toxicology 404–405, 25–32. 4. Bye, W.A., Ma, C., Nguyen, T.M., Parker, C.E., Jairath, V., and East, J.E. (2018). Strategies for detecting colorectal cancer in patients with inflammatory bowel disease: a cochrane systematic review and meta-analysis. Am. J. Gastroenterol. 113, 1801–1809. 5. Chen, H.Y., Lin, Y.M., Chung, H.C., Lang, Y.D., Lin, C.J., Huang, J., Wang, W.C., Lin, F.M., Chen, Z., Huang, H.D., et al. (2012). miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 72, 3631–3641.
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|